Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency?

J. Chorostowska-Wynimko (Warszawa, Poland)

Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Session: Novel molecular and genetic targets in COPD
Session type: Poster Discussion
Number: 373
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Chorostowska-Wynimko (Warszawa, Poland). Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency?. 373

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients
Source: Annual Congress 2008 - COPD
Year: 2008


Mortality of patients with emphysema and alpha-1-antitrypsin deficiency of Pi Z phenotype
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002



Short-term variability of biomakers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004

Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020


Prevalence and phenotype of subjects carrying rare variants in Argentina for alpha1-antitrypsin deficiency
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007


Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency
Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Year: 2012

Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019


MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Which functional alteration is mainly the cause in determining dyspnoeain COPD patients?
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004

Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ)
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011

Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016